资讯

Precision Medicine Online22 小时
Braftovi-Erbitux Combo Approved in China for BRAF V600E-Mutated Colorectal Cancer
Based on data from the BEACON and NAUTICAL studies, regulatory authorities greenlit the combo for later-line patients.